XenoTherapeutics’ takeover of Repare wins near-unanimous vote: What’s at stake for the pipeline

Repare shareholders approve XenoTherapeutics deal. Find out how this nonprofit acquisition could reshape oncology pipeline models.

Repare shareholders approve XenoTherapeutics deal. Find out how this nonprofit acquisition could reshape oncology pipeline models.